Jun. 7 at 9:53 PM
I have relatives who died by cancer, which is why I like to invest in biotech companies who research and develop cancer treatment. First, I bought
$KNTE 20k shares @
$2.53, but this company was merged by
$XOMA and off public. They refunded the amount of cash equal that I spent plus CVR, not bad at all. Second, after a long time watching, I finally bought
$PMVP 3k shares @
$0.90 and
$XLO 4k shares @
$0.67. Both companies have mc up to around
$50M and phase 2 clinic trials, but cash on hand is bigger, mc.
$PMVP is
$185M, while
$XLO is
$85M. Hope they can safely exit Death Valley. Third,
$MAIA data phase 2 looks promised, but cash is too few, around
$10M. Keep watching.
